Bill Search

  • Introduced
    Feb 22, 2024
  • Passed Senate
  • Passed House
  • Signed into Law
SB 241
Connecticut Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
AN ACT CONCERNING THE OFFICE OF HEALTH STRATEGY'S RECOMMENDATIONS REGARDING 340B PROGRAM TRANSPARENCY. To require entities authorized to participate in the federal 340B Drug Pricing Program to report to the Health Systems Planning Unit of the Office of Health Strategy certain information regarding the program, including (1) aggregated acquisition costs, (2) aggregated payment information, (3) the number of claims for prescription drugs under the program, and (4) if the entity is a hospital, the national drug code number for the fifty most frequently dispensed prescription drugs by the hospital under the program.
Last Action See all actions
Senate • Apr 10, 2024: File Number 382 (LCO)
Latest Bill Text See all bill texts
Senate Calendar: Senate Calendar, Apr 22, 2024
Position: 244

Official Summary/Bill Text

Comments on SB 241

Tweets

Whip Lists

Sponsors
Votes
YES: 25
  • Anwar S
  • McCarthy Vahey C
  • Ryan K
  • Kushner J
  • Slap D
  • Marx M
  • Steinberg J
  • Parker J
  • Tercyak P
  • Welander M
  • Klarides-Ditria N
  • Belton K
  • Berger-Girvalo A
  • Cook M
  • Demicco M
  • Denning K
  • Elliott J
  • Genga H
  • Gilchrest J
  • Kavros DeGraw E
  • Keitt S
  • Linehan L
  • Palm C
  • Rader M
  • Rahman M

NO: 11
  • Reddington-Hughes K
  • Somers H
  • Zupkus L
  • Carpino C
  • Dauphinais A
  • DeCaprio M
  • Gordon J
  • Kennedy K
  • Marra T
  • McCarty K
  • Perillo J

ABSENT: 1

Actions
  • Apr 10, 2024 | Senate
    • Reported Out of Legislative Commissioners' Office (LCO)
    • Favorable Report, Tabled for the Calendar, Senate
    • Senate Calendar Number 244
    • File Number 382 (LCO)
  • Apr 04, 2024 | Senate
    • Referred to Office of Legislative Research and Office of Fiscal Analysis 04/09/24 5:00 PM (LCO)
  • Mar 25, 2024 | Senate
    • Filed with Legislative Commissioners' Office (LCO)
  • Mar 22, 2024 | Senate
    • Joint Favorable Substitute (PH)
  • Feb 26, 2024 | Senate
    • Public Hearing 03/01
  • Feb 22, 2024 | Senate
    • Referred to Joint Committee on Public Health